Abstract
Opportunistic infections pose a significant problem in patients receiving immunosuppressive therapy for autoimmune diseases. We present a case of a woman with polymyositis refractory to high-dose steroid and methotrexate, as a consequence of which she developed miliary tuberculosis. Her myositis went into remission after initiation of antitubercular therapy, in spite of bringing down the intensity of immunosuppression. This is the first reported case of myositis undergoing remission after treating intercurrent infection, and illustrates the complex relationship between autoimmune disease and host response to infection.
2015 BMJ Publishing Group Ltd.
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / adverse effects
-
Anti-Inflammatory Agents / administration & dosage*
-
Anti-Inflammatory Agents / adverse effects*
-
Antitubercular Agents / administration & dosage*
-
Drug Therapy, Combination
-
Female
-
Humans
-
Immunocompromised Host
-
Immunosuppression Therapy / adverse effects*
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Middle Aged
-
Polymyositis / drug therapy*
-
Polymyositis / immunology
-
Remission Induction
-
Tuberculosis, Miliary / drug therapy*
-
Tuberculosis, Miliary / etiology*
-
Tuberculosis, Miliary / immunology
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents
-
Antitubercular Agents
-
Methotrexate